Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study

Simpson, S. H.·2006·Canadian Medical Association Journal
DOI 10.1503/cmaj.050748

Cited by (235)

Items 201–235 of 235

  1. Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes
    Lorraine Lucille Lipscombe · 2009 · Annals of Internal Medicine
  2. The Benefit and Risk of Antidiabetic Agents Used in Patients With Heart Disease
    Judy W. M. Cheng, Snehal H. Bhatt, Jennifer D. Goldman · 2008 · Journal of Pharmacy Practice
  3. Zijn sulfonylurea wel veilig?
    Th.F. Veneman · 2014 · Nederlands Tijdschrift voor Diabetologie
  4. Effects of glucose-lowering drugs in patients with diabetes and myocardial infarction
    Linda Mellbin, Klas Malmberg, Lars Rydén · 2011 · Diabetes Management
  5. Kardiovaskuläres Risiko bei Hypoglykämie
    Michael Lehrke · 2013 · Der Diabetologe
  6. Frequency of Control of Blood Glucose in Patients withType 2 Diabetes Mellitus at Tertiary Medical Care Unit
    Mumtaz Ali Shaikh, Khalid A. Shaikh, Muzaffar Ali Shaikh, Dur-E-Yakta, Dargahi Shaikh, Rafi Ahmed Ghori · 2008 · Journal of Liaquat University of Medical & Health Sciences
  7. TYPE 2 DIABETES: THE ROLE OF THE THIAZOLIDINEDIONES*
    David W. Bartels · 2006
  8. Vascular ATP-sensitive potassium channels impact spatial and temporal oxygen transport: implications for sulphonylurea therapy
    Clark T. Holdsworth · 2015 · K-State Research Exchange (Kansas State University)
  9. Efecto del uso de las sulfonilureas en la desviación del segmento ST del electrocardiograma de pacientes con infarto agudo del miocardio
    Eduardo Fernández Campuzano, Karina Olvera Obregón, Eliel Ordaz Rivera, V Juarez · 2007 · Anales Médicos de la Asociación Médica del Centro Médico ABC
  10. TZDs in Combination With Incretins: Synergy in Diabetes Treatment Using these agents in tandem targets the pathophysiology of type 2 diabetes and may be particularly useful in stress-induced diabetes and surgery.
    Stanley S. Schwartz · 2008
  11. Typ-2-Diabetes – Therapie mit insulinotropen Substanzen
    Ch. Rosak · 2006 · Der Diabetologe
  12. ApproachtoTherap y in Patients With Newly Diagnosed Type 2 Diabetes
    Ralph Anthony DeFronzo, Roy Eldor · 2013
  13. Paretoʼs Law and Sulfonylureas
    Alan N. Peiris, Melinda Micklewright, Venkataramanan Gangadharan · 2007 · Southern Medical Journal
  14. Update of the evidence-based guideline of the German Diabetes Association
    Stephan Matthaei, R. Bierwirth, Andreas Fritsche, U. Häring, Monika Kellerer, T. Kunt, Guntram Schernthaner, Erhard G. Siegel, Florian Thienel · 2008
  15. Tratamiento de la diabetes mellitus (II). Hipoglucemiantes no insulínicos
    Francisco Javier Ampudia‐Blasco, Eva Perelló-Camacho · 2016 · Medicine - Programa de Formación Médica Continuada Acreditado
  16. Methods for time-varying exposures
    CM Hazelbag · 2016 · Utrecht University Repository (Utrecht University)
  17. Evaluación de un modelo de diabetes tipo 2 para estudiar la actividad hipoglicemieante de la glibenclamida Assessment of diabetes type 2 model to study the hypoglycemic activity of glibenclamide
    Araceli Amaya Chávez, Emilia Dolores-Ledezma, Patricia Álvarez-Sánchez, Guillermo Ferreira-Rubio, Leobardo Manuel Gómez‐Oliván, Marcela Galar · 2007
  18. Cardiovascular safety of oral antidiabetic therapy in type 2 diabetes mellitus- review article
    Pradyumn Singh, Sudhir K. Yadav, Himanshu Sharma, Manoj Therayil Kumar · 2017 · International Journal of Research in Medical Sciences
  19. Do Sulfonylureas Increase Mortality
    Allan S. Brett · 2006 · Journal watch
  20. Building Evidence to Assess a Drug Safety Signal: the Association between Sulfonylureas and Adverse Cardiovascular Events
    AS Abdelmoneim · 2015 · ERA: Education and Research Archive (University of Alberta)
  21. Present Medical Research: Is it Really Original Research Anymore?
    Udaya M. Kabadi · 2018 · Biomedical Journal of Scientific & Technical Research
  22. Comparative study of control of hyperglycemia and dyslipidemia between two treatment- groups of diabetic patient (Metformin Monotherapy and Metformin + Glimepiride Combination)
    Subhradipta Bhattacharyya, Brijesh Mukherjee · 2019 · IP International Journal of Comprehensive and Advanced Pharmacology
  23. Mesa 3: Efectos cardiovasculares de fármacos antidiabéticos
    Pablo Javier Ávila, Silvana Alejandra Milrad, Mariano Forlino, Sofía Fábregues, Fabiana Vázquez, Cristina Grosso, Ana Schindler, Fabio Zambon, María Virginia Rodríguez, Natalia Carolina Garrido Santos et al. · 2020 · Revista de la Sociedad Argentina de Diabetes
  24. Antidiabéticos en Insuficiencia Cardíaca
    Zulay Andrea García Rojas, Diana Marcela Cristancho Sierra, Amalia Verónica Pérez Papadópulos, Gabriela Ormaechea · 2021 · Revista Uruguaya de Medicina Interna
  25. Treating Type 2 Diabetes Mellitus
    Alexandra L. Migdal, Susan Herzlinger, Martin J. Abrahamson · 2017 · Springer eBooks
  26. Treating Type 2 Diabetes Mellitus
    Alexandra L. Migdal, Susan Herzlinger, Martin J. Abrahamson · 2017 · Springer eBooks
  27. Treating Type 2 Diabetes Mellitus
    Alexandra L. Migdal, Martin J. Abrahamson · 2016 · Springer eBooks
  28. INFECTIONS
    Claudio Ponticelli · 2007 · CRC Press eBooks
  29. Faculty Opinions recommendation of Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review.
    Chim Choy Lang · 2007 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  30. FREQUENCY OF CONTROL OF BLOOD GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES MELLITUUS AT TERTIARY MEDICAL CARE UNIT
    2008 · Journal of Liaquat University of Medical & Health Sciences
  31. Corrections
    2006 · Canadian Medical Association Journal
  32. Corrections
    2006 · Canadian Medical Association Journal
  33. Diyabetin Şifresi
    Deniz Eriş · 2023 · Akademisyen Kitabevi eBooks
  34. The impact of different strategies for modeling associations between medications at low doses and health outcomes: a simulation study and practical application to postpartum opioid use
    Andrew J. Spieker, Margaret A. Adgent, Sarah S. Osmundson, Sharon E. Phillips, Edward F. Mitchel, Ashley A. Leech, Carlos Gabriel Grijalva, Andrew David Wiese · 2024 · American Journal of Epidemiology
  35. Effect of Glucose Management on Coronary Heart Disease Risk in Patients With Type 2 Diabetes
    Kasia J. Lipska, Silvio E. Inzucchi · 2026 · Elsevier eBooks